Studies
Featured
NEW BRIEF: Expanding “Buy America” Rules Would Hurt U.S. Patients and Economy, Hinder Development of Coronavirus Vaccine
Expanding “Buy America” rules for prescription drugs and medical supplies would reduce patient access to drugs and further damage the economy, finds a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute. Click here to download the brief “As the U.S. ...
Featured
NEW ISSUE BRIEF: Expanding Biosimilars Use Could Save Patients, Reduce Out-of-Pocket Costs By 17 Percent
Expanding the use of biosimilars to treat serious illnesses like cancer or auto-immune diseases could reduce a patient’s out-of-pocket costs by 17 percent, finds a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute. Click here to download the study “Biologics ...
Blog
CAPITAL IDEAS: Will California’s Ban on Freelance Work Lead to Blue State Turnaround?
The backlash over California’s Assembly Bill 5, legislation that robs workers of their freedom, was likely not expected by lawmakers. They’re accustomed to an electorate that agreeably goes along with whatever policies they impose, no matter how invasive. The response to AB5, which outlaws, with a few exceptions, freelance and ...
Health Care
PRI Single-Payer Poll Watch
Health care continues to be one of the most contentious public policy issues in the United States. Close to a decade after the passage of the Affordable Care Act, public sentiment continues to evolve: more government control or less? To inform the public on the latest sentiment, PRI has compiled ...
Drug Pricing
NEW STUDY shows that Reforming Supply Chain & Drug Pricing System Will Lower Health Care Costs
As Washington pushes for price caps and government controls to address prescription drug prices, a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute argues that reforming the complex drug supply chain and ending the current drug pricing system that overcharges ...
Health Care
PRI Single-Payer Poll Watch
Health care continues to be one of the most contentious public policy issues in the United States. Close to a decade after the passage of the Affordable Care Act, public sentiment continues to evolve: more government control or less? To inform the public on the latest sentiment, PRI has compiled ...
Blog
CAPITAL IDEAS: The Old City Dumps Aren’t What They Used To Be
Nearly two decades ago, before “ban everything” fever was sweeping through California, San Francisco committed to eliminating a staple of human progress: the modern landfill. The idea, concocted in 2002, was to reach a “zero waste” existence by 2020, which “means that we send zero discards to the landfill or ...
Blackouts
CAPITAL IDEAS – California’s Blackouts: How Did We Get Here and What Can We Do to Keep the Lights On?
Download the Brief Introduction Pacific Gas and Electric of San Francisco began in October 2019 a series of electricity blackouts called “public safety power shutoffs.” The objective was to prevent its equipment from starting wildfires during hot, dry, and windy periods. The Great Blackouts of 2019 plunged nearly 3 million ...
Business & Economics
NEW STUDY finds Overregulation Hurts Immigrant and Low-Income Entrepreneurs Trying to Achieve the American Dream
A new study released today by the nonpartisan Pacific Research Institute finds that government has erected barriers to opportunity that make it very difficult for immigrant and low-income entrepreneurs to lift themselves out of poverty and climb the economic ladder. Click here to download “Entrepreneurship as a Pathway to the ...
Business & Economics
NEW ISSUE BRIEF: Biosimilars Study Shows Massive State and Taxpayer Savings Possible by Expanding Biosimilars Market
Biosimilars have the opportunity to bring significant savings to state Medicaid programs and consumers with commercial insurance according to a new study released today by Pacific Research Institute. “Every state would experience significant savings in the state Medicaid programs from expanding the use of biosimilars compared to the more expensive ...
NEW BRIEF: Expanding “Buy America” Rules Would Hurt U.S. Patients and Economy, Hinder Development of Coronavirus Vaccine
Expanding “Buy America” rules for prescription drugs and medical supplies would reduce patient access to drugs and further damage the economy, finds a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute. Click here to download the brief “As the U.S. ...
NEW ISSUE BRIEF: Expanding Biosimilars Use Could Save Patients, Reduce Out-of-Pocket Costs By 17 Percent
Expanding the use of biosimilars to treat serious illnesses like cancer or auto-immune diseases could reduce a patient’s out-of-pocket costs by 17 percent, finds a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute. Click here to download the study “Biologics ...
CAPITAL IDEAS: Will California’s Ban on Freelance Work Lead to Blue State Turnaround?
The backlash over California’s Assembly Bill 5, legislation that robs workers of their freedom, was likely not expected by lawmakers. They’re accustomed to an electorate that agreeably goes along with whatever policies they impose, no matter how invasive. The response to AB5, which outlaws, with a few exceptions, freelance and ...
PRI Single-Payer Poll Watch
Health care continues to be one of the most contentious public policy issues in the United States. Close to a decade after the passage of the Affordable Care Act, public sentiment continues to evolve: more government control or less? To inform the public on the latest sentiment, PRI has compiled ...
NEW STUDY shows that Reforming Supply Chain & Drug Pricing System Will Lower Health Care Costs
As Washington pushes for price caps and government controls to address prescription drug prices, a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute argues that reforming the complex drug supply chain and ending the current drug pricing system that overcharges ...
PRI Single-Payer Poll Watch
Health care continues to be one of the most contentious public policy issues in the United States. Close to a decade after the passage of the Affordable Care Act, public sentiment continues to evolve: more government control or less? To inform the public on the latest sentiment, PRI has compiled ...
CAPITAL IDEAS: The Old City Dumps Aren’t What They Used To Be
Nearly two decades ago, before “ban everything” fever was sweeping through California, San Francisco committed to eliminating a staple of human progress: the modern landfill. The idea, concocted in 2002, was to reach a “zero waste” existence by 2020, which “means that we send zero discards to the landfill or ...
CAPITAL IDEAS – California’s Blackouts: How Did We Get Here and What Can We Do to Keep the Lights On?
Download the Brief Introduction Pacific Gas and Electric of San Francisco began in October 2019 a series of electricity blackouts called “public safety power shutoffs.” The objective was to prevent its equipment from starting wildfires during hot, dry, and windy periods. The Great Blackouts of 2019 plunged nearly 3 million ...
NEW STUDY finds Overregulation Hurts Immigrant and Low-Income Entrepreneurs Trying to Achieve the American Dream
A new study released today by the nonpartisan Pacific Research Institute finds that government has erected barriers to opportunity that make it very difficult for immigrant and low-income entrepreneurs to lift themselves out of poverty and climb the economic ladder. Click here to download “Entrepreneurship as a Pathway to the ...
NEW ISSUE BRIEF: Biosimilars Study Shows Massive State and Taxpayer Savings Possible by Expanding Biosimilars Market
Biosimilars have the opportunity to bring significant savings to state Medicaid programs and consumers with commercial insurance according to a new study released today by Pacific Research Institute. “Every state would experience significant savings in the state Medicaid programs from expanding the use of biosimilars compared to the more expensive ...
